Home Is Exact Sciences Poised For A Monopoly On Colon Cancer Screening?
 

Keywords :   


Is Exact Sciences Poised For A Monopoly On Colon Cancer Screening?

2015-02-18 11:29:09| Biotech - Topix.net

There will be around 130,000 new cases of colorectal cancer and close to 50,000 deaths due to colorectal cancer in the U.S. in 2015 alone. Cologuard from Exact Sciences is FDA approved and has a screening detection rate of 93% compared to closest competitor at 73%.

Tags: exact sciences cancer screening

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11topps now psa10
27.11 THE ORAL CIGARETTES SUCK MY WORLD
27.11 E
27.113DS .SD()
27.11181
27.11YAMAHA KUSHITANI LL
27.11tsnomi.com
27.11
More »